ATE225805T1 - Hundecoronavirus s gen und verwendung davon - Google Patents
Hundecoronavirus s gen und verwendung davonInfo
- Publication number
- ATE225805T1 ATE225805T1 AT93911346T AT93911346T ATE225805T1 AT E225805 T1 ATE225805 T1 AT E225805T1 AT 93911346 T AT93911346 T AT 93911346T AT 93911346 T AT93911346 T AT 93911346T AT E225805 T1 ATE225805 T1 AT E225805T1
- Authority
- AT
- Austria
- Prior art keywords
- gene
- ecoronavirus
- dog
- ccv
- spike gene
- Prior art date
Links
- 108090000623 proteins and genes Proteins 0.000 title abstract 3
- 208000019698 Cutaneous collagenous vasculopathy Diseases 0.000 abstract 2
- 201000009911 cataract 8 multiple types Diseases 0.000 abstract 2
- 108091028043 Nucleic acid sequence Proteins 0.000 abstract 1
- 150000001413 amino acids Chemical class 0.000 abstract 1
- 239000012634 fragment Substances 0.000 abstract 1
- 208000015181 infectious disease Diseases 0.000 abstract 1
- 239000000203 mixture Substances 0.000 abstract 1
- 238000011321 prophylaxis Methods 0.000 abstract 1
- 238000011282 treatment Methods 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
- C12N2770/00011—Details
- C12N2770/20011—Coronaviridae
- C12N2770/20022—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Virology (AREA)
- Medicinal Chemistry (AREA)
- Oncology (AREA)
- Pharmacology & Pharmacy (AREA)
- Biophysics (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Biochemistry (AREA)
- Communicable Diseases (AREA)
- Gastroenterology & Hepatology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Genetics & Genomics (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Peptides Or Proteins (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US88019492A | 1992-05-08 | 1992-05-08 | |
PCT/US1993/004692 WO1993023423A1 (en) | 1992-05-08 | 1993-05-07 | Canine coronavirus s gene and uses therefor |
Publications (1)
Publication Number | Publication Date |
---|---|
ATE225805T1 true ATE225805T1 (de) | 2002-10-15 |
Family
ID=25375695
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AT93911346T ATE225805T1 (de) | 1992-05-08 | 1993-05-07 | Hundecoronavirus s gen und verwendung davon |
Country Status (10)
Country | Link |
---|---|
EP (1) | EP0640098B1 (de) |
JP (1) | JP3245169B2 (de) |
AT (1) | ATE225805T1 (de) |
AU (1) | AU670092B2 (de) |
CA (1) | CA2135200C (de) |
DE (1) | DE69332375T2 (de) |
DK (1) | DK0640098T3 (de) |
ES (1) | ES2182827T3 (de) |
PT (1) | PT640098E (de) |
WO (1) | WO1993023423A1 (de) |
Families Citing this family (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH08501931A (ja) * | 1992-05-08 | 1996-03-05 | スミスクライン・ビーチャム・コーポレイション | コロナウイルスに対するワクチン接種用組成物および方法 |
GB2316681B (en) * | 1993-09-16 | 1998-04-15 | Dimminaco Ag Sa Ltd | Antigenically active proteins/polypeptides and coronavirus vaccines containing the same |
FR2828405B1 (fr) | 2001-08-09 | 2005-06-24 | Virbac Sa | Vaccin anti-coronavirus |
GB0217434D0 (en) * | 2002-07-27 | 2002-09-04 | Royal Vetinary College | Biological material |
GB0315323D0 (en) | 2003-07-01 | 2003-08-06 | Royal Veterinary College | Vaccine composition |
US9023366B2 (en) | 2003-07-01 | 2015-05-05 | The Royal Veterinary College | Vaccine composition for vaccinating dogs against canine infectious respiratory disease (CIRD) |
CN113583096B (zh) * | 2020-05-01 | 2023-06-30 | 清华大学 | SARS-CoV-2 Spike蛋白受体结合域二聚体及其应用 |
CN112079906B (zh) * | 2020-07-15 | 2022-11-04 | 张影 | 一种新型冠状病毒刺突蛋白、相关生物材料及其应用、检测试纸和检测试剂盒 |
CN113945714B (zh) * | 2020-07-16 | 2023-01-31 | 南京蓬勃生物科技有限公司 | 新型冠状病毒中和抗体类药物中和能力的检测方法 |
Family Cites Families (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS63123385A (ja) * | 1986-09-05 | 1988-05-27 | デュファル・インテルナチオナル・レセールフ・ベー・ヴェー | 新規抗原的活性蛋白質およびぺプチド、並びにネコ科感染性腹膜炎ウイルスワクチン |
HUT45559A (en) * | 1987-01-16 | 1988-07-28 | Duphar Int Res | Process for producing new proteines and peptides of antigene activity and vaccines against virus of infective gastritis-enteritis |
US4904468A (en) * | 1987-06-08 | 1990-02-27 | Norden Laboratories, Inc. | Canine coronavirus vaccine |
CA2005291C (en) * | 1988-12-30 | 1999-01-26 | Beverly Dale | Feline infectious peritonitis virus diagnostic tools |
ATE256746T1 (de) * | 1991-04-25 | 2004-01-15 | Akzo Nobel Nv | Subeinheits-impfstoff gegen hundecoronavirus |
EP0524672A1 (de) * | 1991-06-27 | 1993-01-27 | Duphar International Research B.V | CCV-Impfstoff |
JPH08501931A (ja) * | 1992-05-08 | 1996-03-05 | スミスクライン・ビーチャム・コーポレイション | コロナウイルスに対するワクチン接種用組成物および方法 |
-
1993
- 1993-05-07 AU AU42515/93A patent/AU670092B2/en not_active Ceased
- 1993-05-07 DE DE69332375T patent/DE69332375T2/de not_active Expired - Fee Related
- 1993-05-07 PT PT93911346T patent/PT640098E/pt unknown
- 1993-05-07 DK DK93911346T patent/DK0640098T3/da active
- 1993-05-07 JP JP50381394A patent/JP3245169B2/ja not_active Expired - Fee Related
- 1993-05-07 AT AT93911346T patent/ATE225805T1/de not_active IP Right Cessation
- 1993-05-07 WO PCT/US1993/004692 patent/WO1993023423A1/en active IP Right Grant
- 1993-05-07 CA CA002135200A patent/CA2135200C/en not_active Expired - Fee Related
- 1993-05-07 ES ES93911346T patent/ES2182827T3/es not_active Expired - Lifetime
- 1993-05-07 EP EP93911346A patent/EP0640098B1/de not_active Expired - Lifetime
Also Published As
Publication number | Publication date |
---|---|
JPH07508421A (ja) | 1995-09-21 |
AU4251593A (en) | 1993-12-13 |
CA2135200A1 (en) | 1993-11-25 |
DK0640098T3 (da) | 2002-10-28 |
WO1993023423A1 (en) | 1993-11-25 |
DE69332375T2 (de) | 2003-02-13 |
EP0640098A1 (de) | 1995-03-01 |
PT640098E (pt) | 2003-01-31 |
DE69332375D1 (de) | 2002-11-14 |
CA2135200C (en) | 2001-03-27 |
EP0640098A4 (de) | 1997-01-02 |
AU670092B2 (en) | 1996-07-04 |
EP0640098B1 (de) | 2002-10-09 |
JP3245169B2 (ja) | 2002-01-07 |
ES2182827T3 (es) | 2003-03-16 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
IL148079A0 (en) | Human ctla-4 antibodies and compositions containing the same | |
FI962247A (fi) | Uudet apoptoosia muuntavat proteiinit, niitä koodaava DNA ja näiden käyttömenetelmät | |
ATE244304T1 (de) | Verfahren zur veränderung des essverhaltens, dafür verwendbare verbindungen und dna, die einen hypothalamischen atypischen neuropeptid y/peptid yy rezeptor (y5) kodiert | |
IL136690A0 (en) | Inhibition of raf kinase using symmetrical and unsymmetrical substituted diphenyl ureas | |
IL129592A0 (en) | 5-HT1f agonists | |
GR3023233T3 (en) | Inhibitors of dipeptidyl-aminopeptidase type iv | |
MY131388A (en) | Inhibitors of hiv protease useful for the treatment of aids. | |
ATE411805T1 (de) | Organo-phosphorverbindungen zur aktivierung von gamma/delta-t-zellen | |
MX9704030A (es) | 1,1-dioxidos de 2-heterocicliloxi y tiometil-1,2,5-tiadiazolidin-3-ona y composiciones y metodo de uso de los mismos. | |
IL162917A0 (en) | A lysin from bacteriophage and pharmaceutical compositions containing the same | |
FI972308A0 (fi) | 2-substituoituja 1,2,5-tiadiatsolidin-3-oni-1,1-dioksideja ja niitä sisältäviä koostumuksia ja menetelmiä niiden käyttämiseksi | |
ATE304052T1 (de) | Humane checkpointkinase, hcds1, zusammensetzungen und verfahren | |
ATE190352T1 (de) | Dorsalgewebe beeinflussender faktor und zusammensetzungen | |
ATE225805T1 (de) | Hundecoronavirus s gen und verwendung davon | |
EP0387802A3 (de) | 5-Substituierte 1,4-Dihydro-4-oxonaphthyridin-3-carbonsäure als antibakterielles Mittel | |
FI952094A0 (fi) | Ihmisen serotoniinireseptoria (5-HT4B)koodaava DNA ja sen käyttö | |
ATE225171T1 (de) | Aminosäurederivate zur behandlung von schlaganfall | |
DE69735039D1 (de) | Acetylhydrolase des Plättchen aktivierenden Faktors, und entsprechendes Gen | |
ID25478A (id) | Agonis 5-ht1f | |
ATE312179T1 (de) | Serin-threonin-kinase enthaltendes mittel zur tumortherapie und tumordiagnose | |
ATE179990T1 (de) | Cyclische pentapeptide mit beta-turn und gamma- turn | |
DE60234843D1 (de) | Modifizierte peptide und deren verwendung zur behandlung von autoimmunkrankheiten | |
DE3777359D1 (de) | Aminosaeuresequenz des menschlichen alpha 2-plasmininhibitors und cdns sowie diese aminosaeuresequenz codierende genomische dns. | |
AU1278700A (en) | Novel therapeutic use of 1,6-dimethyl-8beta-hydroxymethyl-10alpha-methoxyergoline |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
UEP | Publication of translation of european patent specification |
Ref document number: 0640098 Country of ref document: EP |
|
REN | Ceased due to non-payment of the annual fee |